Division of Cardiology, Department of Internal Medicine, Lo-Tung Poh-Ai Hospital.
Department of Nursing, St. Mary's Junior College of Medicine, Nursing and Management.
J Atheroscler Thromb. 2021 Oct 1;28(10):1052-1062. doi: 10.5551/jat.59386. Epub 2020 Nov 7.
AIMS: Type 2 diabetes mellitus (T2DM) is no longer regarded as a coronary risk equivalent, and heterogeneity of cardiovascular risk exists, suggesting that further risk stratification should be mandatory. This study aimed to determine the prevalence and clinical predictors of coronary artery calcium (CAC) score, and evaluate the CAC score as a predictor of cardiovascular outcome in a large asymptomatic T2DM cohort. METHODS: A total of 2,162 T2DM patients were recruited from a Diabetes Shared Care Network and the CAC score was measured. Cardiovascular outcomes were obtained for 1,928 patients after a follow-up of 8.4 years. Multiple regression analysis and Cox proportional hazard regression were applied to identify clinical predictors of CAC and calculate the incidence and hazard ratios (HRs) for all-cause mortality and cardiovascular events by CAC category. RESULTS: Of the recruited patients, 96.8% had one or more risk factors. The distribution of CAC scores was as follows: CAC=0 in 24.2% of the patients, 0 <CAC ≤ 100 in 41.5%, 100 <CAC ≤ 400 in 20.3%, CAC >400 in 14.7%. The multivariable predictor of increased CAC included age (years) (odds ratio, 1.07; 95% confidence interval, 1.06-1.08), male sex (1.82; 1.54-2.17), duration (years) of T2DM (1.07; 1.05-1.09), and multiple risk factors (1.94; 1.28-2.95). Increasing severity of CAC was associated with higher all-cause or cardiac mortality and higher incident cardiovascular events. The HRs for cardiac death or major cardiac events in CAC >400 vs CAC=0 were 8.67 and 10.52, respectively ( p<0.001) Conclusion: CAC scoring provides better prognostication of cardiovascular outcome than traditional risk factors in asymptomatic T2DM patients, and may allow identifying a high-risk subset for enhancing primary prevention.
目的:2 型糖尿病(T2DM)不再被视为冠心病的等效风险因素,且心血管风险存在异质性,这表明应强制性进行进一步的风险分层。本研究旨在确定冠状动脉钙(CAC)评分的患病率和临床预测因素,并评估 CAC 评分在大型无症状 T2DM 队列中的心血管结局预测价值。
方法:从糖尿病共享护理网络中招募了 2162 名 T2DM 患者,并测量了 CAC 评分。在随访 8.4 年后,获得了 1928 名患者的心血管结局数据。应用多元回归分析和 Cox 比例风险回归分析来识别 CAC 的临床预测因素,并根据 CAC 类别计算全因死亡率和心血管事件的发生率和风险比(HRs)。
结果:在招募的患者中,96.8%的患者有一个或多个危险因素。CAC 评分的分布如下:CAC=0 的患者占 24.2%,0 <CAC≤100 的患者占 41.5%,100 <CAC≤400 的患者占 20.3%,CAC>400 的患者占 14.7%。CAC 增加的多变量预测因素包括年龄(岁)(优势比,1.07;95%置信区间,1.06-1.08)、男性(1.82;1.54-2.17)、T2DM 病程(年)(1.07;1.05-1.09)和多种危险因素(1.94;1.28-2.95)。CAC 严重程度的增加与全因或心脏死亡率的升高以及心血管事件的发生率升高相关。在 CAC>400 与 CAC=0 相比,心脏死亡或主要心脏事件的 HR 分别为 8.67 和 10.52(p<0.001)。结论:与传统危险因素相比,CAC 评分能更好地预测无症状 T2DM 患者的心血管结局,并且可能可以识别出高危亚组,以加强一级预防。
J Atheroscler Thromb. 2021-10-1
Mayo Clin Proc. 2013-8
Eur Heart J Cardiovasc Imaging. 2016-11
Nephrol Dial Transplant. 2020-7-1
Quant Imaging Med Surg. 2025-9-1
Int J Cardiovasc Imaging. 2024-10
JACC Cardiovasc Imaging. 2015-5